Literature DB >> 9606614

Optimal treatment of phantom limb pain in the elderly.

R Baron1, G Wasner, V Lindner.   

Abstract

Phantom limb and stump pain is a common sequela of amputation. In geriatric patients with an amputated limb and multiple other illnesses, drug therapy may be problematic and invasive techniques may be risky. Interactions between pathophysiological mechanisms in the peripheral and central nervous systems may be responsible for the initiation and maintenance of chronic phantom limb and stump pain. These mechanisms include: (i) peripheral damage to nociceptive fibres and dorsal root ganglion cells, which acquire abnormal sensitivity to mechanical, thermal and chemical stimuli; (ii) the prolonged sensitisation of central nociceptive 'second order' neurons in the dorsal horn of the spinal cord, which become hyperexcitable and start responding to nonnoxious stimuli; and (iii) the degeneration of nociceptive neurons, which may trigger the anatomical sprouting of low threshold mechanosensitive terminals to form connections with central nociceptive neurons. This may subsequently induce functional synaptic reorganisation in the dorsal horn. The provision of a pain-free perioperative interval using regional anaesthetic techniques is likely to reduce the incidence of phantom limb pain. The therapy of manifest pain is difficult, and treatment should start as soon as possible to prevent chronic pain. In the acute state, the infusion of calcitonin and oral opioid analgesics have proven to be helpful, while established phantom limb pain may respond to antidepressants, anticonvulsants and drugs that mimic or enhance gamma-aminobutyric acid function. Pharmacological treatment should be combined with transcutaneous electrical nerve stimulation, sympathetic blockade and psychotherapy. In addition, new therapeutic strategies are now being tested; examples include capsaicin, new anticonvulsants and N-methyl-D-aspartate antagonists. Patients with severe pain should be referred to a pain specialist to ensure optimal and timely interventional pain management.

Entities:  

Mesh:

Year:  1998        PMID: 9606614     DOI: 10.2165/00002512-199812050-00003

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  133 in total

1.  Peripheral nerve injury triggers central sprouting of myelinated afferents.

Authors:  C J Woolf; P Shortland; R E Coggeshall
Journal:  Nature       Date:  1992-01-02       Impact factor: 49.962

2.  Continuous postoperative infusion of a regional anesthetic after an amputation of the lower extremity. A randomized clinical trial.

Authors:  M S Pinzur; P G Garla; T Pluth; L Vrbos
Journal:  J Bone Joint Surg Am       Date:  1996-10       Impact factor: 5.284

3.  Chronic opioid therapy as alternative treatment for post-herpetic neuralgia.

Authors:  M Pappagallo; J N Campbell
Journal:  Ann Neurol       Date:  1994       Impact factor: 10.422

4.  Meta-analysis of NSAIDs: contribution of drugs, doses, trial designs, and meta-analytic techniques.

Authors:  P C Gøtzsche
Journal:  Scand J Rheumatol       Date:  1993       Impact factor: 3.641

5.  A-fibers mediate mechanical hyperesthesia and allodynia and C-fibers mediate thermal hyperalgesia in a new model of causalgiform pain disorders in rats.

Authors:  Y Shir; Z Seltzer
Journal:  Neurosci Lett       Date:  1990-07-17       Impact factor: 3.046

6.  Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy.

Authors:  M B Max; S A Lynch; J Muir; S E Shoaf; B Smoller; R Dubner
Journal:  N Engl J Med       Date:  1992-05-07       Impact factor: 91.245

7.  Chronic phantom and stump pain among American veterans: results of a survey.

Authors:  Richard A Sherman; Crystal J Sherman; Laura Parker
Journal:  Pain       Date:  1984-01       Impact factor: 6.961

8.  Epidural stimulation for peripheral vascular disease: 10 years experience.

Authors:  G Broggi; D Servello; A Franzini; C Giorgi; S Visintini
Journal:  Ital J Neurol Sci       Date:  1993-05

9.  Clinical trial of propranolol in post-traumatic neuralgia.

Authors:  J W Scadding; P D Wall; Wynn C B Parry; D M Brooks
Journal:  Pain       Date:  1982-11       Impact factor: 6.961

10.  Continuous subcutaneous administration of the N-methyl-D-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of post-herpetic neuralgia.

Authors:  Per Kristian Eide; Audun Stubhaug; Ivar Øye; Harald Breivik
Journal:  Pain       Date:  1995-05       Impact factor: 6.961

View more
  2 in total

Review 1.  Pain in nursing home residents: management strategies.

Authors:  D K Weiner; J T Hanlon
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 2.  Pharmacological treatments for persistent non-malignant pain in older persons.

Authors:  Thorsten Nikolaus; Andrej Zeyfang
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.